| BioTrends Research Group LLCPosted on:12 Apr 12 - PharmiWeb.com (press release) |
|
|
PharmiWeb.com (press release) In the US the market for erythropoietic stimulating agents (ESAs) has undergone significant shifting over the past several years as new clinical data, updated product labeling and a new reimbursement system in dialysis have all changed the market |